Adenosinergic Axis and Immune Checkpoint Combination Therapy in Tumor:A New Perspective for Immunotherapy Strategy
Zhaoyun Liu1*, Xiaohan Liu1*, Hongli Shen1, Xintong Xu1, Xianghong Zhao1, Rong Fu1
Addresses:1 Department of Hematology, Tianjin Medical University General Hospital, 154 Anshan Street, Heping District, Tianjin 300052, PR China.
*These authors contributed equally to this manuscript.
Corresponding author: Rong Fu
Department of Hematology, Tianjin Medical University General Hospital, 154 Anshan Street, Heping District, Tianjin 300052, PR China. Telephone: (086) 02260817181. Fax number: (086) 02260817181. E-mail:furong8369@tmu.edu.cn
The authors declare no potential conflicts of interest.
This work was supported by the National Natural Science Foundation of China Youth Project (grant no. 81900131), the National Natural Science Foundation of China Youth Project (grant no. 8210010129), the Tianjin Municipal Natural Science Foundation (grant no. 18JCQNJC80400), the Tianjin Education Commission Research Project (grant no. 2018KJ043), the Tianjin Education Commission Research Project (grant no. 2018KJ045), and the Tianjin Science and Technology Planning Project (no. 20YFZCSY00060).Tianjin Municipal Health Commission Youth Project(grant no. TJWJ2021QN001);Medjaden Academy & Research Foundation for Young Scientists (Grant No. MJR20221011);Tianjin Key Medical Discipline(Specialty) Construction project.